Status:
COMPLETED
This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic
Lead Sponsor:
Sandoz
Conditions:
Dry Skin
Eligibility:
FEMALE
50+ years
Phase:
NA
Brief Summary
The primary objective of this study was to investigate if AmLactin® Rapid Relief improves the skin through desquamation and moisturization via D-SQUAME analysis. AmLactin® Rapid Relief is an over-the-...
Eligibility Criteria
Inclusion
- healthy female (confirmed by medical history) with Fitzpatrick skin types I-VI
- dry, rough skin on the anterior shins (defined as Grade 3-4 on the dermatologist evaluation of the skin);
Exclusion
- \- Had any visible skin disease at the assessment site which, in the opinion of the Investigator, would interfere with the evaluation of the test site
Key Trial Info
Start Date :
March 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2019
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04085809
Start Date
March 26 2019
End Date
April 8 2019
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sandoz Investigational Site
High Point, North Carolina, United States, 27262